230 related articles for article (PubMed ID: 20888494)
1. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
[TBL] [Abstract][Full Text] [Related]
2. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent signaling in Dupuytren's disease.
Hadeed JG; Bond JE; Selim MA; Bergeron A; Levin LS; Levinson H
Hand (N Y); 2011 Jun; 6(2):159-64. PubMed ID: 22654698
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
7. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
8. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
Moyer KE; Banducci DR; Graham WP; Ehrlich HP
Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
[TBL] [Abstract][Full Text] [Related]
9. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
11. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
12. The collagen changes of Dupuytren's contracture.
Murrell GA; Francis MJ; Bromley L
J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
14. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells.
Rosenfeldt HM; Amrani Y; Watterson KR; Murthy KS; Panettieri RA; Spiegel S
FASEB J; 2003 Oct; 17(13):1789-99. PubMed ID: 14519658
[TBL] [Abstract][Full Text] [Related]
16. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate induces cell contraction via calcium-independent/Rho-dependent pathways in undifferentiated skeletal muscle cells.
Formigli L; Meacci E; Vassalli M; Nosi D; Quercioli F; Tiribilli B; Tani A; Squecco R; Francini F; Bruni P; Zecchi Orlandini S
J Cell Physiol; 2004 Jan; 198(1):1-11. PubMed ID: 14584038
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
Tse R; Howard J; Wu Y; Gan BS
BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
[TBL] [Abstract][Full Text] [Related]
19. The biochemistry of Dupuytren's disease.
Badalamente MA; Hurst LC
Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
[TBL] [Abstract][Full Text] [Related]
20. MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction.
Wilkinson JM; Davidson RK; Swingler TE; Jones ER; Corps AN; Johnston P; Riley GP; Chojnowski AJ; Clark IM
Biochim Biophys Acta; 2012 Jun; 1822(6):897-905. PubMed ID: 22342364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
